Concepedia

Patrik Guggisberg

PG

Statistics

Publications

4

Citations

70

H-Index

4

Active since

2019

Affiliations

MSD (Switzerland)(Current)

University of Basel

Merck & Co., Inc., Rahway, NJ, USA (United States)

University Hospital of Basel

Patrik Guggisberg is an author at MSD (Switzerland) specializing in vaccination, oncology, and comparative cost-effectiveness.

Publications per year

2019–2022

4

Publications

4

Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland

Arjun Bhadhuri, Ralph P. Insinga, Patrik Guggisberg et al. · Swiss Medical Weekly · 2019 · 28 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland

Ulrich Heininger, Matthew Pillsbury, Salome Samant et al. · The Pediatric Infectious Disease Journal · 2021 · 16 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland

André B. Kind, Andrew Pavelyev, Smita Kothari et al. · BMC Public Health · 2020 · 14 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Understanding physician’s knowledge and perception of chronic cough in Switzerland

Jörg D. Leuppi, Patrik Guggisberg, Daniel Koch et al. · Current Medical Research and Opinion · 2022 · 12 citations · Full text

Medicine, Health Sciences, Internal Medicine +12

1–4 of 4